Lenvima

Active Ingredient(s): Lenvatinib
FDA Approved: * February 13, 2015
Pharm Company: * EISAI INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Lenvima Overview

Lenvatinib (trade name Lenvima) is an anti-cancer drug for the treatment of certain kinds of thyroid cancer, and potentially for other cancers as well. It was developed by Eisai Co. and acts as a multiple kinase inhibitor against the VEGFR1, VEGFR2 and VEGFR3 kinases.[1] Contents 1 Medical uses 2 Adverse effects 3 Interactions 4 Pharmacology 4.1 Mechanism of action 4.2 Pharmacokinetics 5 Chemistry 6 History 7 Brand names 8 References Medical uses Lenvatinib is appr...

Read more Lenvima Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lenvatinib

Recent Lenvima Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lenvatinib
  • Capsule: 10mg, 4mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Lenvima: (8 results)

Sorted by National Drug Code
  • 62856-704 Lenvima 4 mg Oral Capsule by Eisai Inc.
  • 62856-708 Lenvima 4 mg Oral Capsule by Eisai Inc.
  • 62856-710 Lenvima 10 mg Oral Capsule by Eisai Inc.
  • 62856-712 Lenvima 4 mg Oral Capsule by Eisai Inc.
  • 62856-714 Lenvima Kit by Eisai Inc.
  • 62856-718 Lenvima Kit by Eisai Inc.
  • 62856-720 Lenvima 10 mg Oral Capsule by Eisai Inc.
  • 62856-724 Lenvima Kit by Eisai Inc.

Other drugs which contain Lenvatinib or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA